Positive progress

On development of Cereno’s unique concept for the prevention of blood clots…

Cereno and CTC team up for clinical study

Formulation update


Interim report Q1 24 May 2017

Interim report Q2 & H1 23 August 2017

Interim report Q3 14 November 2017

Cereno Scientific

(Video in Swedish) Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots - to be used on the global market for the treatment of complications resulting from thrombosis-related cardiovascular diseases.

About Cereno Scientific